Publication date: 8 December 2026 Source: Molecular Therapy Nucleic Acids, Volume 37, Issue 4 Author(s): Matthew J. Gold, Douglas G. Millar, Jun Liu, Haritha Menon, Yury Karpov, Kirstin Olsen, Liliam Teixeira Oliveira, Charlotte Dubé, Charles W. Tran, Alisha R. Elford, Jordan A. Schwartz, Rajesh Krishnan Gopalakrishna Panicker, Eric G. Marcusson, Pamela S. Ohashi, Natalia Martin Orozco
Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8+ T cells. // Molecular Therapy: Nucleic Acids. – URL: https://www.sciencedirect.com/science/article/pii/S2162253126002477?dgcid=rss_sd_all
Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8+ T cells. Molecular Therapy: Nucleic Acids. https://www.sciencedirect.com/science/article/pii/S2162253126002477?dgcid=rss_sd_all
“Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8+ T cells.” Molecular Therapy: Nucleic Acids.
@article{article59490,
title = {Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8+ T cells},
journal = {Molecular Therapy: Nucleic Acids},
url = {https://www.sciencedirect.com/science/article/pii/S2162253126002477?dgcid=rss_sd_all}
}
Publication date: 8 December 2026 Source: Molecular Therapy Nucleic Acids, Volume 37, Issue 4 Author(s): Madison A. Schaefer, Brandon Wilbanks, Irene K. Yan, Alexis M. Sosic, Julia Driscoll, Rory L. Smoot, Tushar Patel, L. James Maher,...